Zai Lab in-licenses Entasis’s broad-spectrum antibiotic in APAC

Drug Discovery |  News | 0 Comment | 26 Apr, 2018

Singapore – Shanghai-based Zai Lab Limited inks an exclusive license agreement with privately held Entasis Therapeutics for the rights to broad-spectrum intravenous antibiotic ETX2514...Read more

Pfizer vaccine receives FDA's breakthrough therapy designation

Drug Discovery |  News | 0 Comment | 25 Apr, 2018

Pfizer recently announced that its lead Meningococcal Group B Vaccine TRUMENBA received Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA) for active immuniza...Read more

Zymeworks, Celgene expand bispecific antibody partnership

Drug Discovery |  News | 0 Comment | 24 Apr, 2018

Singapore - Zymeworks, a clinical-stage biopharmaceutical company developing multifunctional therapeutics, announced that Celgene Corporation has exercised its right to expand its collabora...Read more

UCB to acquire Proximagen’s midazolam nasal spray

Drug Discovery |  News | 0 Comment | 20 Apr, 2018

Singapore- Belgium based UCB announced an agreement to acquire the rights to Proximagen's Midazolam Nasal Spray (USL261), an anti-epilepsy drug (AED) developed as an intended rescue tr...Read more

J&J ramps up pricing for Imbruvica

Drug Discovery |  News | 0 Comment | 19 Apr, 2018

Singapore- Johnson & Johnson will implement a new pricing and dosage scheme for cancer med IMBRUVICA (ibrutinib) conveniently ahead of research that suggests the drug, which costs ~$148...Read more

OBI Pharma gets FDA clearance for new drug application

Drug Discovery |  News | 0 Comment | 19 Apr, 2018

OBI Pharma, Inc., a Taiwan biopharma company announced that the U.S. Food and Drug Administration (FDA) has cleared an investigational new drug (IND) application for a Phase I/II study of O...Read more

Perrigo launches medication for Frequent Heartburn

Drug Discovery |  News | 0 Comment | 13 Apr, 2018

Perrigo and its Israel based partner, Dexcel Pharma announced the launch of store brand omeprazole delayed release orally disintegrating tablets 20mg (omeprazole ODT), an over-the-counter (...Read more

Pfizer initiates Phase I trials for DMD

Drug Discovery |  News | 0 Comment | 13 Apr, 2018

Pfizer recently announced that it has initiated a Phase 1b clinical trial for its mini-dystrophin gene therapy candidate, PF-06939926, in boys with Duchenne muscular dystrophy (DMD). The fi...Read more

Strides Shasun’s allergy relief drug gets USFDA approval

Drug Discovery |  News | 0 Comment | 12 Apr, 2018

Strides Shasun said its wholly-owned subsidiary has received approval from the US health regulator for Cyproheptadine Hydrochloride tablets, used to relieve allergy symptoms.  Strides...Read more

Alexion Pharmaceuticals to acquire Wilson Therapeutics for $855mn

Drug Discovery |  News | 0 Comment | 12 Apr, 2018

  M&A deal making continues with Alexion Pharmaceuticals swapping up Wilson Therapeutics AB for USD 855 million. Swedish drugmaker Wilson Therapeutics is a biopharmaceutical compa...Read more

USFDA approves Perrigo’s OTC heartburn medicine

Drug Discovery |  News | 0 Comment | 11 Apr, 2018

Singapore - Perrigo Company plc announced that it has received final approval from the U.S. Food & Drug Administration for the store brand OTC equivalent of Nexium 24HR (esomeprazo...Read more

Ionis Pharma, AstraZeneca to advance new drug for NASH

Drug Discovery |  News | 0 Comment | 11 Apr, 2018

US-based Ionis Pharmaceuticals,  the leader in antisense therapeutics, recently announced that it has licensed IONIS-AZ6-2.5-LRx, or AZD2693, to AstraZeneca following advance...Read more

Yuhan Corporation collaborates with Syntekabio for AI platform

Drug Discovery |  News | 0 Comment | 10 Apr, 2018

As per reports from a leading South Korean daily, the country’s leading pharmaceutical firm Yuhan Corporation has collaborated with bio-informatics company Syntekabio to develop new d...Read more

AstraZeneca's oncology drugs receive regulatory boost

Drug Discovery |  News | 0 Comment | 06 Apr, 2018

Global pharma giant AstraZeneca’s oncology drugs received regulatory boost with bothe the US FDA and EU accepting regulatory submissions for its drug candidates for cancer. AstraZen...Read more

Aleafia steps-up battle against opioid crisis

Drug Discovery |  News | 0 Comment | 06 Apr, 2018

Singapore - Aleafia Health announced that it has launched a new opiate replacement program across its 23 Aleafia/Canabo clinic network. As the opioid health-crisis continues across No...Read more

USFDA approves Proteostasis’s triple combination program for CF

Drug Discovery |  News | 0 Comment | 04 Apr, 2018

Singapore — Proteostasis Therapeutics, a clinical stage biopharmaceutical company dedicated to the discovery and development of ground-breaking therapies to treat cystic fibrosis (CF)...Read more

Strides Shasun’s generic Ibuprofen receives USFDA approval

Drug Discovery |  News | 0 Comment | 02 Apr, 2018

Drug firm Strides Shasun has received approval from the US health regulator for generic Ibuprofen capsules, 200 mg, used for relieving pain. The company's wholly-owned subsidiary Strides P...Read more

C4X Discovery signs licensing agreement with Indivior

Drug Discovery |  News | 0 Comment | 02 Apr, 2018

UK based drug discovery company C4X Discovery Holdings plc has announced that it has signed a licensing agreement with Indivior UK Limited to further develop and commercialise C4XD’s ...Read more